S10 Ep9: FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL

OncLive® On Air - A podcast by OncLive® On Air

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored
Podcast artwork

Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated CLL/SLL; key efficacy and safety data from the BRUIN trial; and guidelines for pirtobrutinib use in clinical practice in the CLL/SLL patient population.

Visit the podcast's native language site